risks of bpc-157 bpc 157 human clinical trials safety evidence BPC-157 Dangers: What Happens When

A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection

[PMC free article] [PubMed] [Google Scholar] 2.DeFoor MT, Dekker TJ: Injectable therapeutic peptidesAn adjunct to regenerative medicine and sports performance

BPC-157, derived from a gastric protein, has been extensively studied for its ability to accelerate wound healing, protect the gastrointestinal lining, and enhance tendon regeneration

BPC-157 is an exception because it is not an exogenous peptide being introduced into a foreign environment: it is a peptide found naturally in human gastric juice at low concentrations, where it appears to serve a mucosal protective function

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans